LH

SEC source: 0001127602-23-003698 · form4.xml · derivative · entry 3

Seltz Judith C · CIK 0001791228 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 930

Underlying: Common Stock · 280 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003698 · form4.xml · nonDerivative · entry 1

Seltz Judith C · CIK 0001791228 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,881.9485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003696 · form4.xml · derivative · entry 3

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock · 267 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003696 · form4.xml · nonDerivative · entry 1

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003700 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,714

Underlying: Common Stock · 560 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003700 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,247.4022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003694 · form4.xml · derivative · entry 3

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,107

Underlying: Common Stock · 300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003694 · form4.xml · nonDerivative · entry 1

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,640.7592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003692 · form4.xml · derivative · entry 3

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497

Underlying: Common Stock · 150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003692 · form4.xml · nonDerivative · entry 1

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,140.2194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003544 · form4.xml · nonDerivative · entry 3

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,340.7592

F4 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2 · balance_after: Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003538 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,687.4022

F3 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

SEC source: 0001127602-23-003547 · form4.xml · derivative · entry 3

Seltz Judith C · CIK 0001791228 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,210

Underlying: Common Stock · 220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003547 · form4.xml · nonDerivative · entry 2

Seltz Judith C · CIK 0001791228 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,601.9485

F3 · kind: Stock withholding to satisfy tax withholding obligations.

F2 · balance_after: Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003547 · form4.xml · nonDerivative · entry 1

Seltz Judith C · CIK 0001791228 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,678.9485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · balance_after: Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003544 · form4.xml · derivative · entry 4

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,407

Underlying: Common Stock · 237 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003544 · form4.xml · nonDerivative · entry 2

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,513.7592

F3 · kind: Stock withholding to satisfy tax withholding obligations.

F2 · balance_after: Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003544 · form4.xml · nonDerivative · entry 1

van der Vaart Sandra D · CIK 0001537208 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,577.7592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · balance_after: Amount includes 26.2103 shares acquired on June 30, 2022 and 27.5309 shares acquired on December 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003538 · form4.xml · derivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,274

Underlying: Common Stock · 443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003538 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,011.4022

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003538 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,130.4022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003542 · form4.xml · derivative · entry 3

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647

Underlying: Common Stock · 117 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003542 · form4.xml · nonDerivative · entry 2

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,990.2194

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003542 · form4.xml · nonDerivative · entry 1

Wilkinson Peter J · CIK 0001398138 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,031.2194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003541 · form4.xml · derivative · entry 3

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,367

Underlying: Common Stock · 220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003541 · form4.xml · nonDerivative · entry 2

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003541 · form4.xml · nonDerivative · entry 1

Summy Amy B. · CIK 0001805303 · EVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003536 · form4.xml · derivative · entry 3

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,251

Underlying: Common Stock · 2,773 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003536 · form4.xml · nonDerivative · entry 2

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,556

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003536 · form4.xml · nonDerivative · entry 1

Schechter Adam H · CIK 0001376841 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003532 · form4.xml · derivative · entry 3

Kirchgraber Paul R · CIK 0001791393 · CEO, Covance Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,454

Underlying: Common Stock · 443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003532 · form4.xml · nonDerivative · entry 2

Kirchgraber Paul R · CIK 0001791393 · CEO, Covance Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,332

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003532 · form4.xml · nonDerivative · entry 1

Kirchgraber Paul R · CIK 0001791393 · CEO, Covance Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003530 · form4.xml · derivative · entry 3

EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,077

Underlying: Common Stock · 767 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003530 · form4.xml · nonDerivative · entry 2

EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,403

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003530 · form4.xml · nonDerivative · entry 1

EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,609

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-003527 · form4.xml · derivative · entry 3

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,274

Underlying: Common Stock · 443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003527 · form4.xml · nonDerivative · entry 2

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,717.7624

F3 · kind: Stock withholding to satisfy tax withholding obligations.

F2 · balance_after: Amount includes 20.9824 shares acquired on December 31, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003527 · form4.xml · nonDerivative · entry 1

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,861.7624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · balance_after: Amount includes 20.9824 shares acquired on December 31, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-23-003526 · form4.xml · derivative · entry 3

BERBERIAN LANCE · CIK 0001102900 · EVP, CIO & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,541

Underlying: Common Stock · 297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-23-003526 · form4.xml · nonDerivative · entry 2

BERBERIAN LANCE · CIK 0001102900 · EVP, CIO & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,697

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-23-003526 · form4.xml · nonDerivative · entry 1

BERBERIAN LANCE · CIK 0001102900 · EVP, CIO & CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-23-001267 · form4.xml · derivative · entry 1

Pike Thomas · CIK 0001471570 · Pres & CEO Clinical Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,960

Underlying: Common Stock · 16,960 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.

F2 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.

SEC source: 0001127602-22-025222 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,687.4022

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

SEC source: 0001127602-22-025109 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,803.4022

F3 · kind: Stock withholding to satisfy tax withholding obligations.

F2 · balance_after: Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-22-025108 · form4.xml · nonDerivative · entry 2

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,397.78

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-22-025109 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,717

Underlying: Common Stock · 2,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.

F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.

F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-22-025109 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, President-Diagnostics Lab

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,697.4022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2 · balance_after: Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

SEC source: 0001127602-22-025108 · form4.xml · derivative · entry 3

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,717

Underlying: Common Stock · 2,010 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.

F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-22-025108 · form4.xml · nonDerivative · entry 1

Caveney Brian J · CIK 0001717915 · EVP, President of Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,291.78

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.